Osteonecrose da cabeça femoral por uso de corticosteroides no tratamento da COVID-19: relato de caso
DOI:
https://doi.org/10.11606/issn.1679-9836.v103i4e-204032Palavras-chave:
osteonecrose, fêmur, corticosteroide, COVID-19, Necrose Avascular da Cabeça FemoralResumo
A osteonecrose não traumática da cabeça femoral (ONCF) é caracterizada pela morte celular dos osteócitos e alterações nos osteoblastos e osteoclastos, frequentemente causada pelo uso prolongado de corticosteroides. Outros fatores de risco incluem doenças autoimunes, álcool, radioterapia e infecções. O presente relato descreve o caso de um homem de 55 anos que desenvolveu ONCF após tratamento com corticosteroides para COVID-19. A ONCF pode ser insidiosa, manifestando-se com dor e limitação de movimento, sendo a ressonância magnética (RM) o método diagnóstico mais eficaz. O tratamento varia de conservador a cirúrgico, dependendo do estágio da doença. O diagnóstico precoce e o acompanhamento multidisciplinar são essenciais para um melhor prognóstico. Pesquisas futuras devem focar em desenvolver diretrizes de tratamento da COVID-19 que reduzam a incidência de ONCF, explorando alternativas terapêuticas seguras e eficazes.
Downloads
Referências
Liu LH, Zhang QY, Sun W, Li ZR, Gao FQ. Corticosteroid-induced Osteonecrosis of the Femoral Head: Detection, Diagnosis, and Treatment in Earlier Stages. Chin Med J [Internet]. 2017;130(21):2601-7. Doi: http://dx.doi.org/10.4103/0366-6999.217094
Miyahara HS, Rosa BB, Hirata FY, Gurgel HMC, Ejnisman L, Vicente JRN. What is the role of core decompression in the early stages of osteonecrosis of the femoral head? Evaluation of the surgical result by functional score and radiological follow-up. Rev Bras Ortop [Internet]. 2018;53(5):537-42. Doi: http://dx.doi.org/10.1016/j.rboe.2018.07.013
Souza MH, Ranzoni LV, Ejnisman L, Vicente JRN, Croci AT, Campos GHM. Osteonecrose da cabeça femoral: Artigo de atualização. Rev Bras Ortop (Sao Paulo) [Internet]. 2022;57(03):351-9. https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0041-1736308
Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop [Internet]. 2015;6(8):590-601. Doi: http://dx.doi.org/10.5312/wjo.v6.i8.590
Gomes L. Osteonecrose da Cabeça Femoral. In: Cirurgia Preservadora do Quadril Adulto [Internet]. unknown; 2015. p. 429-48.
Inácio FM, Inácio F. Necrose avascular da cabeça do fêmur do diagnóstico ao tratamento: um estudo de revisão de literatura. Braz J Dev [Internet]. 2022;8(10):69056-63. https://brazilianjournals.com/ojs/index.php/BRJD/article/view/53477
Wang A, Ren M, Wang J. The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature. Gene [Internet]. 2018;671:103-9. Doi: http://dx.doi.org/10.1016/j.gene.2018.05.091
Lavernia CJ, Sierra RJ, Grieco FR. Osteonecrosis of the femoral head. J Am Acad Orthop Surg [Internet]. 1999;7(4):250-61. Doi: http://dx.doi.org/10.5435/00124635-199907000-00005
Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update. J Bone Joint Surg Am [Internet]. 2015;97(19):1604-27. Doi: http://dx.doi.org/10.2106/JBJS.O.00071
Guerado E, Caso E. The physiopathology of avascular necrosis of the femoral head: an update. Injury [Internet]. 2016;47 Suppl 6:S16-26. Doi: http://dx.doi.org/10.1016/S0020-1383(16)30835-X
Kaneshiro Y, Oda Y, Iwakiri K, Masada T, Iwaki H, Hirota Y, et al. Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis. Clin Pharmacol Ther [Internet]. 2006;80(4):396-402. Doi: http://dx.doi.org/10.1016/j.clpt.2006.07.004
Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg [Internet]. 2014;22(7):455-64. Doi: http://dx.doi.org/10.5435/JAAOS-22-07-455
Wang C, Peng J, Lu S. Summary of the various treatments for osteonecrosis of the femoral head by mechanism: A review. Exp Ther Med [Internet]. 2014;8(3):700-6. Doi: http://dx.doi.org/10.3892/etm.2014.1811
Fukushima W, Fujioka M, Kubo T, Tamakoshi A, Nagai M, Hirota Y. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res [Internet]. 2010;468(10):2715-24. Doi: http://dx.doi.org/10.1007/s11999-010-1292-x
Cui L, Zhuang Q, Lin J, Jin J, Zhang K, Cao L, et al. Multicentric epidemiologic study on six thousand three hundred and ninety five cases of femoral head osteonecrosis in China. Int Orthop [Internet]. 2016;40(2):267-76. Doi: http://dx.doi.org/10.1007/s00264-015-3061-7
Tokuhara Y, Wakitani S, Oda Y, Kaneshiro Y, Masada T, Kim M, et al. Low levels of steroid-metabolizing hepatic enzyme (cytochrome P450 3A) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose. J Orthop Sci [Internet]. 2009;14(6):794-800. Doi: http://dx.doi.org/10.1007/s00776-009-1400-5
Huang R, Zhan Q, Hu W, Yang R, Cheng N, Han Y, et al. Association of ABCB1 and CYP450 Gene Polymorphisms and their DNA Methylation Status with Steroid-Induced Osteonecrosis of the Femoral Head in the Chinese Population. Genet Test Mol Biomarkers [Internet]. 2020;24(12):789-97. Doi: http://dx.doi.org/10.1089/gtmb.2020.0201
Zhang Z, Li Y, Liu H, Shi J, Li X, Jiang W. ABCB1 polymorphisms associated with osteonecrosis of the femeral head. Int J Clin Exp Pathol [Internet]. 2015;8(11):15240-4. https://www.ncbi.nlm.nih.gov/pubmed/26823873
Mont MA, Pivec R, Banerjee S, Issa K, Elmallah RK, Jones LC. High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review. J Arthroplasty [Internet]. 2015;30(9):1506-12. Doi: http://dx.doi.org/10.1016/j.arth.2015.03.036
Sakellariou E, Argyropoulou E, Karampinas P, Galanis A, Varsamos I, Giannatos V, et al. A Comprehensive Review of COVID-19-Infection- and Steroid-Treatment-Associated Bone Avascular Necrosis: A Multi-Study Analysis. Diagnostics (Basel) [Internet]. 2024;14(3). Doi: http://dx.doi.org/10.3390/diagnostics14030247
Shetty GM. Double Trouble-COVID-19 and the Widespread Use of Corticosteroids: Are We Staring at an Osteonecrosis Epidemic? Indian J Orthop [Internet]. 2022;56(2):226-36. Doi: http://dx.doi.org/10.1007/s43465-021-00546-8
Veizi E, Erdoğan Y, Sezgin BS, Karaman Y, Kılıçarslan K, Fırat A. The painful joint after COVID-19 treatment: A study on joint osteonecrosis following COVID-19-related corticosteroid use. Jt Dis Relat Surg [Internet]. 2023;34(1):75-83. Doi: http://dx.doi.org/10.52312/jdrs.2023.895
Velchov V, Georgiev P, Tserovski S, Tsenkov T, Alexiev V. Corticosteroid-Associated Avascular Necrosis of the Femoral Head in Patients with Severe COVID-19: A Single-Center Study. Med Sci Monit [Internet]. 2023;29:e940965. Doi: http://dx.doi.org/10.12659/MSM.940965
Parikh S, Gomez O, Davis T, Lyon Z, Corces A. Avascular Necrosis as a Sequela of COVID-19: A Case Series. Cureus [Internet]. 2023;15(2):e35368. Doi: http://dx.doi.org/10.7759/cureus.35368
Zhang S, Wang C, Shi L, Xue Q. Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic. Drug Des Devel Ther [Internet]. 2021;15:983-95. Doi: http://dx.doi.org/10.2147/DDDT.S298691
Hassan AAA, Khalifa AA. Femoral head avascular necrosis in COVID-19 survivors: a systematic review. Rheumatol Int [Internet]. 2023;43(9):1583-95. Doi: http://dx.doi.org/10.1007/s00296-023-05373-8
Zhao R, Wang H, Wang X, Feng F. Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis. Osteoporos Int [Internet]. 2017;28(3):1027-34. Doi: http://dx.doi.org/10.1007/s00198-016-3824-z
Tan RSJ, Ng KT, Xin CE, Atan R, Yunos NM, Hasan MS. High-Dose versus Low-Dose Corticosteroids in COVID-19 Patients: a Systematic Review and Meta-analysis. J Cardiothorac Vasc Anesth [Internet]. 2022;36(9):3576-86. Doi: http://dx.doi.org/10.1053/j.jvca.2022.05.011
Hofmann H, Geier M, Marzi A, Krumbiegel M, Peipp M, Fey GH, et al. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem Biophys Res Commun [Internet]. 2004;319(4):1216-21. Doi: http://dx.doi.org/10.1016/j.bbrc.2004.05.114
Zhao FC, Li ZR, Guo KJ. Clinical analysis of osteonecrosis of the femoral head induced by steroids. Orthop Surg [Internet]. 2012;4(1):28-34. Doi: http://dx.doi.org/10.1111/j.1757-7861.2011.00163.x
Wang C, Sun W, Ling S, Wang Y, Wang X, Meng H, et al. AAV-Anti-miR-214 Prevents Collapse of the Femoral Head in Osteonecrosis by Regulating Osteoblast and Osteoclast Activities. Mol Ther Nucleic Acids [Internet]. 2019;18:841-50. Doi: http://dx.doi.org/10.1016/j.omtn.2019.09.030
Camporesi EM, Vezzani G, Bosco G, Mangar D, Bernasek TL. Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty [Internet]. 2010;25(6 Suppl):118-23. Doi: http://dx.doi.org/10.1016/j.arth.2010.05.005
Hernigou P, Trousselier M, Roubineau F, Bouthors C, Chevallier N, Rouard H, et al. Stem Cell Therapy for the Treatment of Hip Osteonecrosis: A 30-Year Review of Progress. Clin Orthop Surg [Internet]. 2016;8(1):1-8. Doi: http://dx.doi.org/10.4055/cios.2016.8.1.1
Sultan AA, Mohamed N, Samuel LT, Chughtai M, Sodhi N, Krebs VE, et al. Classification systems of hip osteonecrosis: an updated review. Int Orthop [Internet]. 2019;43(5):1089-95. Doi: http://dx.doi.org/10.1007/s00264-018-4018-4
Ito H, Matsuno T, Omizu N, Aoki Y, Minami A. Mid-term prognosis of non-traumatic osteonecrosis of the femoral head. J Bone Joint Surg Br [Internet]. 2003;85(6):796-801. https://www.ncbi.nlm.nih.gov/pubmed/12931794
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2024 Mateus Gonçalves de Sena Barbosa, Rafaela Luiza Vilela de Souza, Maria Eduarda Santos Affi Peixoto, Arthur Carvalho de Oliveira Gonçalves, Luiz Gabriel Gonçalves Cherain, Adriano Correa Cordeiro, Lucas Hiron Ulhoa Carvalho, Raphael Antunes Lacerda, Josy Maria Maximiano Silva
Este trabalho está licenciado sob uma licença Creative Commons Attribution-ShareAlike 4.0 International License.
